Syncor finalizes imaging center acquisitions
Comprehensive Medical Imaging (CMI), a wholly owned subsidiary of radiopharmaceutical firm Syncor, has completed its acquisition of 13 imaging centers from U.S. Diagnostic, which is getting out of the imaging center business (SCAN,
Comprehensive Medical Imaging (CMI), a wholly owned subsidiary of radiopharmaceutical firm Syncor, has completed its acquisition of 13 imaging centers from U.S. Diagnostic, which is getting out of the imaging center business (SCAN, 8/16/00).
Syncor said in a statement that the acquisition goes along with its strategy of regional concentration.
CMI paid about $31 million in cash for the 13 centers and assumed around $1.3 million in debt, which is expected to be accretive for year 2000 earnings.
Other than the CMI activity, Syncor is a provider of nuclear pharmacy services and radiopharmaceuticals. The company owns two PET radiopharmaceutical production facilities.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
